Variant report

Variant	rs17079076
Chromosome Location	chr6:150262097-150262098
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	SUZ12	chr6:150261103-150262100	H1-hESC	embryonic stem cell:	n/a	n/a

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:150255655..150257664-chr6:150259479..150262477,4	K562	blood:
2	chr6:150254783..150257862-chr6:150259479..150262603,4	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ULBP2-1	chr6:150261044-150262631	XLOC_005501
2	lnc-ULBP2-1	chr6:150261044-150262631	XLOC_005501
3	lnc-ULBP2-1	chr6:150261044-150262766	NONHSAT115525

No data

Variant related genes	Relation type
ULBP2	TF binding region
ENSG00000216621	Chromatin interaction

Extended variants
information (count: 44 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:38)

rs_ID	r²[population]
rs10499261	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.84[AMR][1000 genomes];0.81[ASN][1000 genomes]
rs12523670	0.81[AMR][1000 genomes]
rs12524576	0.81[ASN][1000 genomes]
rs12529569	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap]
rs12662588	0.83[AMR][1000 genomes]
rs12664934	0.86[AMR][1000 genomes]
rs1535955	0.91[CHB][hapmap];0.80[JPT][hapmap]
rs17079064	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs17079068	0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs17079081	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs17079083	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs17079087	1.00[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs17079117	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.89[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs17079127	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.84[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs17079130	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap];0.86[AMR][1000 genomes];0.81[ASN][1000 genomes]
rs2018074	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap]
rs2343264	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap]
rs4084448	0.86[AMR][1000 genomes];0.82[ASN][1000 genomes]
rs4133317	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4273697	0.82[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs4283897	0.88[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs4354166	0.91[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs4425606	0.95[CHB][hapmap]
rs4473866	0.88[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs4504486	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.92[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs4591860	0.88[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs57923090	0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs59712181	0.86[AMR][1000 genomes];1.00[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs60324886	0.94[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs61233579	0.89[AMR][1000 genomes];0.92[ASN][1000 genomes]
rs6557194	0.88[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs7740713	1.00[CEU][hapmap];0.86[AMR][1000 genomes];0.81[ASN][1000 genomes]
rs7744918	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.86[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs7745903	1.00[CEU][hapmap];1.00[CHB][hapmap];0.90[JPT][hapmap]
rs7760608	1.00[CEU][hapmap];1.00[CHB][hapmap];0.91[JPT][hapmap];0.84[AMR][1000 genomes];0.81[ASN][1000 genomes]
rs7764321	0.91[AMR][1000 genomes];0.96[ASN][1000 genomes]
rs7767362	0.86[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs9791229	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.89[AMR][1000 genomes];0.84[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv886764	chr6:150114745-150393683	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
2	nsv517022	chr6:150145001-150426272	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
3	nsv886765	chr6:150198491-150288722	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
4	esv1817805	chr6:150209592-150268708	Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
5	esv3332714	chr6:150259037-150275045	Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
6	nsv970174	chr6:150262064-150263659	Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs17079076	ULBP2	cis	multi-tissue	Pritchard

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150260200-150262600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
2	chr6:150260400-150262200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
3	chr6:150260400-150262400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
4	chr6:150260400-150262600	Weak transcription	Right Atrium	heart
5	chr6:150260400-150262600	Weak transcription	HMEC	breast
6	chr6:150260600-150262200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
7	chr6:150260600-150262400	Weak transcription	Pancreas	Pancrea
8	chr6:150260600-150262400	Weak transcription	Right Ventricle	heart
9	chr6:150260800-150262400	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
10	chr6:150261400-150262400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr6:150261400-150264000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
12	chr6:150261600-150262200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
13	chr6:150261600-150262400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
14	chr6:150261600-150262600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
15	chr6:150261800-150262200	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
16	chr6:150261800-150262200	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
17	chr6:150261800-150262400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
18	chr6:150261800-150262400	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
19	chr6:150261800-150262400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
20	chr6:150261800-150262400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr6:150261800-150262600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
22	chr6:150261800-150262600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
23	chr6:150261800-150262600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
24	chr6:150261800-150263200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr6:150262000-150262200	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
26	chr6:150262000-150262400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
27	chr6:150262000-150262400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr6:150262000-150262400	Bivalent Enhancer	Brain Anterior Caudate	brain
29	chr6:150262000-150262400	Bivalent Enhancer	Brain Germinal Matrix	brain
30	chr6:150262000-150262400	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr6:150262000-150262600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links